AGP Picks
View all

Following health and wellness news from Arkansas

Provided by AGP

Arkansas Healthcare Report: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Arkansas Healthcare Report.

Press releases published on May 15, 2026

Lifeward Reports First Quarter 2026 Financial Results
Immuneering Reports First Quarter 2026 Financial Results and Provides Business Updates
BriaCell Expands Pipeline to Include an Ovarian Cancer Immunotherapy Candidate, Bria-OVA+™
MiNK Therapeutics Reports First Quarter 2026 Financial Results and Advances iNKT Cell Therapy Platform Into Randomized Clinical Validation
Palvella Therapeutics Announces New Data from the Phase 2 TOIVA Trial of QTORIN™ Rapamycin in Cutaneous Venous Malformations Presented at the 83rd Annual Meeting of the Society for Investigative Dermatology
Annovis Provides Corporate Updates and Reports First Quarter 2026 Financial Results
Profusa Announces Listing Transfer to The Nasdaq Capital Market
Intercontinental ICU Air Ambulance Transport Highlights Growing Need for Continuous In-Flight Medical Care
Davos Alzheimer’s Collaborative Celebrates Andrea Pfeifer, Retiring CEO of AC Immune, for Her Contributions to Alzheimer’s Policy, Research and Care
Kanghong Pharmaceutical and Vanotech Announce Positive Phase 2b Results for KH607 in Major Depressive Disorder
Protara Therapeutics Announces Positive Updated 12-Month Data Demonstrating Durable Responses in the Fully Enrolled BCG-Naïve Cohort of the Ongoing Phase 2 ADVANCED-2 Trial of TARA-002 in NMIBC
Instil Bio Reports First Quarter 2026 Financial Results and Provides Corporate Update
Kymera Therapeutics Announces Presentations on KT-621, a First-In-Class, Oral STAT6 Degrader, at the Society for Investigative Dermatology and American Thoracic Society Congresses
Traws Pharma Provides Business Highlights and Reports Q1 2026 Financial Results
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BioXcel Therapeutics Provides Business Update and  Reports First Quarter 2026 Financial Results
Satellos Reports First Quarter 2026 Financial Results and Highlights Company Progress
Indaptus Therapeutics Reports First Quarter 2026 Financial Results and Provides Corporate Update
Telix Announces Collaborations to Explore PSMA-PET Imaging in Emerging Prostate Cancer Treatment Approaches
Positive Interim Data from Cohorts 1 and 2 of Tenaya’s RIDGE™-1 Phase 1b/2 Clinical Trial of TN-401 Demonstrated Consistent Reductions in Arrhythmia Burden for Adults with PKP2-associated ARVC

Share us

on your social networks:

Sign up for:

Arkansas Healthcare Report

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.